Fri, Sep 24, 2:15 PM - 3:30 PM
Virtual
Development of Real-World Endpoints and Utility in Regulatory Decision-Making
Panel Discussion (303549)
*
Bill Capra, Roche / Genentech
*
Michael Gaffney, Pfizer Inc.
*
Donna Rivera, FDA
*
Meghna Kamath Samant, Flatiron Health
*
Lorenzo Trippa, Harvard T.H. Chan School of Public Health
